How NICE may be outflanked

BMJ. 2006 May 27;332(7552):1268-71. doi: 10.1136/bmj.332.7552.1268.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Review
  • Comment

MeSH terms

  • Cost-Benefit Analysis
  • Drug Costs
  • Drug Industry / economics
  • Focus Groups
  • Health Care Rationing* / economics
  • Patient Advocacy
  • Pharmaceutical Preparations* / economics
  • Practice Guidelines as Topic
  • Quality-Adjusted Life Years
  • State Medicine* / economics
  • United Kingdom

Substances

  • Pharmaceutical Preparations